A drug long used in Eastern Europe for neurodegenerative disorders but never approved in the United States was better than speech therapy alone for stroke-related aphasia.
Ted Bosworth is a journalist who writes for Medscape, MDEdge, and has been featured in MediQuality. His articles cover a range of medical topics, including dermatology, cardiology, migraine, and the latest news in the healthcare field. Ted's work focuses on providing valuable insights and information to healthcare professionals and keeping readers up-to-date with the latest developments in the medical world.